http://cpr.sagepub.com/content/24/1/41.full.pdf+html
In summary, the value of TTE as a first-line screening tool for conditions predisposing to SCD remains to be proven, largely because of additional cost, lack of expertise and infrastructure, and no evidence for incremental diagnostic value compared to ECG alone.